Vimarsana
Biggest News Aggregation in the World

Page 14 - Herpes Simplex News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Herpes Simplex. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Herpes Simplex Today - Breaking & Trending Today

BBCNEWS BBC News June 4, 2024 08:27:00 - Vimarsana News

BBCNEWS BBC News June 4, 2024 08:27:00

A thorough investigation is under way into the death last friday of 22—year—old mahsa amini. speaking in new york, mr raisi condemned the nationwide protests sparked by her death where at least 23 people have been killed but this figure is thought to have increased overnight. a new type of cancer therapy that uses a common virus to infect and destroy harmful cells is showing big promise in early human trials, say uk scientists. the drug is a weakened form of the cold sore virus, herpes simplex, that has been modified to kill tumours. however, larger and longer studies will be needed, but e...

SARS-CoV-2 generates amyloid in cerebral spinal fluid - Vimarsana News

SARS-CoV-2 generates amyloid in cerebral spinal fluid

In a recent study posted to the bioRxiv* preprint server, an international team of researchers demonstrated amyloid aggregation due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human cerebrospinal fluid (CSF).

Synthetic mucin gels against HIV-1 and HSV-2 transmission - Vimarsana News

Synthetic mucin gels against HIV-1 and HSV-2 transmission

In a new study, researchers assessed the effectiveness of synthetic mucin gels in the inhibition of human immunodeficiency virus-1 (HIV-1) and herpes simplex virus-2 (HSV-2) Transmission.

Virios Therapeutics Announces Top-Line Results from Phase 2b Study of IMC-1 in Fibromyalgia - Vimarsana News

Virios Therapeutics Announces Top-Line Results from Phase 2b Study of IMC-1 in Fibromyalgia

Virios Therapeutics, Inc. , a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, including fibromyalgia ,... | September 19, 2022

Virios Therapeutics Says Phase 2b Study Of IMC-1 In Fibromyalgia Fails To Meet Primary Endpoint - Vimarsana News

Virios Therapeutics Says Phase 2b Study Of IMC-1 In Fibromyalgia Fails To Meet Primary Endpoint

(RTTNews) - Virios Therapeutics, Inc. (VIRI), a development-stage biotechnology company focused on chronic diseases, including fibromyalgia or FM,...